Roundtable Discussion
Time: 11:30 am
day: Conference Day 2
Details:
- Discovery Table: Understanding target biology and patient population characteristics, such as genotype-phenotype relations, prevalence and target amenability, for genetic vs acquired hearing disorders
- Preclinical Table: Developing novel in vitro and in vivo preclinical models beyond mice and replicating the underlying biology of the human inner ear structures
- Clinical Table: Discussing strategies to optimize clinical trial design and patient recruitment for varying patient populations with genetic and acquired hearing disorders
Moderator Feedback & Audience Debate: Moderators will be assigned to each roundtable to facilitate discussion and collate the findings. Following the roundtable discussions, they will present back to the entire delegation and open up a wider audience debate.
